Systemic dexpanthenol as a novel treatment for female pattern hair loss
April 2021
in “Journal of Cosmetic Dermatology”
TLDR Dexpanthenol improves hair growth and satisfaction in women without side effects.
Systemic dexpanthenol may be a promising treatment for female pattern hair loss, with a high satisfaction rate reported by women who received 500 mg intramuscular dexpanthenol weekly. The study found it to be safe and effective in improving patient satisfaction without any reported side effects. Dexpanthenol has anti-oxidative and anti-inflammatory effects and is typically used for other conditions. Women who received 500 mg of intramuscular DXP weekly for 2 months experienced improved hair growth and quality of life with no significant adverse effects. However, further research is needed to confirm its effectiveness.
View this study on onlinelibrary.wiley.com →
Cited in this study
research Dexpanthenol may be a novel treatment for male androgenetic alopecia: Analysis of nine cases
Dexpanthenol improves hair growth in male baldness.
research Prostaglandins in androgenetic alopecia in 12 men and four female
research Prostaglandin D2 Uses Components of ROS Signaling to Enhance Testosterone Production in Keratinocytes
Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.
research Genetics and other factors in the aetiology of female pattern hair loss
Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.
research Distinguishing diffuse alopecia areata (AA) from pattern hair loss (PHL) using CD3+ T cells
CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.
research Female Pattern Hair Loss: a clinical and pathophysiological review
Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.
research Destruction of the arrector pili muscle and fat infiltration in androgenic alopecia
Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.
research Hair through the female life cycle
Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.
research Kenogen in Female Androgenetic Alopecia
Kenogen increases with hair loss in women.
research Molecular mechanisms of androgenetic alopecia
AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.
research A hair growth questionnaire for use in the evaluation of therapeutic effects in men
The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.
research Chronic telogen effluvium: Increased scalp hair shedding in middle-aged women
Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.
Related
research A clinico-epidemiological study of scalp hair loss in children (0–18 years) in Kota Region, South-East Rajasthan
About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.
research Disorders of Hair
The document's conclusion cannot be provided because the document is not readable or understandable.
research Hair loss in children: Common and uncommon causes; clinical and epidemiological study in Jordan
The most common causes of hair loss in Jordanian children are fungal infections, autoimmune hair loss, and hair shedding after fever, with zinc deficiency also being a notable cause.
research Diagnosis of Hair Loss: Clinical features of common causes of hair loss.
The document describes the signs of different common types of hair loss.
research Diagnosis and management of the hair loss patient.
Most hair loss cases are caused by four main conditions, and understanding them is key to treatment.